This statistic depicts the compound annual growth rate (CAGR) of oncology biomarker clinical trials started worldwide between 2000 and 2018, by cancer type. During these years, brain/glioma/CNS cancer clinical trials had the highest CAGR of 25.1 percent, followed closely by lung cancer clinical trials with a CAGR of 24.9 percent.
CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type*
* Trials looking at two or more indications are repeat counted for each indication.
** Potential pan-tumor biomarker trials were determined based on a proxy
of trial activity that could potentially lead to a pan-tumor label and included
oncology biomarker clinical trials in Phase 2,3 or 4 with >five specified
tumors per trial or
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
L.E.K. Consulting, & Personalized Medicine Coalition. (November 26, 2019). CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type* [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1092749/cagr-oncology-biomarker-clinical-trials-by-cancer-type-globally/
L.E.K. Consulting, und Personalized Medicine Coalition. "CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type*." Chart. November 26, 2019. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1092749/cagr-oncology-biomarker-clinical-trials-by-cancer-type-globally/
L.E.K. Consulting, Personalized Medicine Coalition. (2019). CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type*. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1092749/cagr-oncology-biomarker-clinical-trials-by-cancer-type-globally/
L.E.K. Consulting, and Personalized Medicine Coalition. "Cagr of Oncology Biomarker Clinical Trials Worldwide from 2000 to 2018, by Cancer Type*." Statista, Statista Inc., 26 Nov 2019, https://www.statista.com/statistics/1092749/cagr-oncology-biomarker-clinical-trials-by-cancer-type-globally/
L.E.K. Consulting & Personalized Medicine Coalition, CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type* Statista, https://www.statista.com/statistics/1092749/cagr-oncology-biomarker-clinical-trials-by-cancer-type-globally/ (last visited December 22, 2024)
CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type* [Graph], L.E.K. Consulting, & Personalized Medicine Coalition, November 26, 2019. [Online]. Available: https://www.statista.com/statistics/1092749/cagr-oncology-biomarker-clinical-trials-by-cancer-type-globally/
